Skip to content

Clinical trials

Completed Phase 2 Neuralgia trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neuralgia Phase: Phase 2 Status: Completed Clear all

79 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20022
20042
20053
20063
20079
20086
20094
20105
20115
20125
20136
20143
20151
20162
20174
20183
20195
20202
20211
20221
20243

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed79

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline4
National Institute of Dental and Craniofacial Research (NIDCR)3
NeurogesX3
XenoPort, Inc.3
AbbVie (prior sponsor, Abbott)2
AstraZeneca2
Aziende Chimiche Riunite Angelini Francesco S.p.A2
EpiCept Corporation2
University Hospital, Clermont-Ferrand2
University of California, San Diego2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neuralgia79
Pain16
Neuralgia, Postherpetic15
Diabetic Neuropathies12
Herpes Zoster9
Chronic Pain7
Peripheral Nervous System Diseases7
Spinal Cord Injuries5
Agnosia4
Diabetes Mellitus4

Trials

Showing 1 to 25 of 79. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.